Diabetes Insipidus Clinical Trials

4 recruiting

Diabetes Insipidus Trials at a Glance

8 actively recruiting trials for diabetes insipidus are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Basel, St Louis, and Atlanta. Lead sponsors running diabetes insipidus studies include University Hospital, Basel, Switzerland, Children's Hospital of Fudan University, and Children's Oncology Group.

Browse diabetes insipidus trials by phase

Treatments under study

About Diabetes Insipidus Clinical Trials

Looking for clinical trials for Diabetes Insipidus? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetes Insipidus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetes Insipidus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

GerminomaBasal Ganglia GerminomaDiabetes Insipidus+3 more
Children's Oncology Group240 enrolled107 locationsNCT06368817
Recruiting

The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU

CopeptinDiabetes Insipidus, NeurohypophysealCopeptin Blood Levels+1 more
Children's Hospital of Fudan University100 enrolled1 locationNCT06742060
Recruiting
Not Applicable

Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency

Diabetes InsipidusAVP Deficiency
University Hospital, Basel, Switzerland28 enrolled1 locationNCT07361263
Recruiting
Phase 2

Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus

Central Diabetes Insipidus (cDI)
University Hospital, Basel, Switzerland112 enrolled2 locationsNCT06036004
Recruiting

Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study

Diabetes MellitusDiabetes InsipidusWolfram Syndrome+3 more
Washington University School of Medicine5,000 enrolled1 locationNCT02841553
Recruiting
Not Applicable

Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls

Central Diabetes Insipidus
University Hospital, Basel, Switzerland24 enrolled1 locationNCT06789705
Recruiting

National Registry of Rare Kidney Diseases

Denys-Drash SyndromeTuberous SclerosisAutosomal Recessive Polycystic Kidney Disease+81 more
UK Kidney Association35,000 enrolled1 locationNCT06065852
Recruiting

Validation of a Postoperative Diabetes Insipidus Prediction Tool In Patients Undergoing Skull Base Surgery

Diabetes Insipidus
Mendel Castle-Kirszbaum100 enrolled4 locationsACTRN12621000857808